Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647

Sort by:

Mycosis Fungoides (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Mycosis Fungoides (Oncology) - Drugs in Development, 2021 SUMMARY Mycosis Fungoides (Oncology) - Drugs in Development, 2021 provides an overview of the Mycosis Fungoides pipeline landscape. The report...

April 2021 65 pages

Myelofibrosis (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Myelofibrosis (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Myelofibrosis (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Myelofibrosis pipeline lan...

April 2021 125 pages

Myeloperoxidase (MPO or EC 1.11.2.2) - Drugs in Development, 2021

US$ 3,000.00

Myeloperoxidase (MPO or EC 1.11.2.2) - Drugs in Development, 2021 SUMMARY Myeloperoxidase (MPO or EC 1.11.2.2) - Drugs in Development, 2021 provides in depth analysis on Myeloperoxidase (MPO or EC 1.1...

April 2021 30 pages

Myeloproliferative Disorders (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Myeloproliferative Disorders (Oncology) - Drugs in Development, 2021 SUMMARY Myeloproliferative Disorders (Oncology) - Drugs in Development, 2021 provides an overview of the Myeloproliferative Disorde...

April 2021 90 pages

Myopia (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Myopia (Ophthalmology) - Drugs in Development, 2021 SUMMARY Myopia (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Myopia pipeline landscape. The report provides comprehensive...

April 2021 35 pages

Myotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Myotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Myotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Myotonic Dystrophy pipeline land...

April 2021 75 pages

Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Myxoid Liposarcoma pipeline landscape. The rep...

April 2021 35 pages

NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Polymerase or PARP or EC 2.4.2.30) - Drugs in Development, 2021

US$ 3,000.00

NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Polymerase or PARP or EC 2.4.2.30) - Drugs in Development, 2021 SUMMARY NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Po...

April 2021 65 pages

NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1 or MT-ND1 or EC 7.1.1.2) - Drugs in Development, 2021

US$ 3,000.00

NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1 or MT-ND1 or EC 7.1.1.2) - Drugs in Development, 2021 SUMMARY NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1...

April 2021 30 pages

NADPH Oxidase (NOX or EC 1.6.3.1) - Drugs in Development, 2021

US$ 3,000.00

NADPH Oxidase (NOX or EC 1.6.3.1) - Drugs in Development, 2021 SUMMARY NADPH Oxidase (NOX or EC 1.6.3.1) - Drugs in Development, 2021 provides in depth analysis on NADPH Oxidase (NOX or EC 1.6.3.1) ta...

April 2021 45 pages

Na+/K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pump or EC 7.2.2.13) - Drugs in Development, 2021

US$ 3,000.00

Na+/K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pump or EC 7.2.2.13) - Drugs in Development, 2021 SUMMARY Na+/K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pu...

April 2021 35 pages

Natural Killer Cell Lymphomas (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Natural Killer Cell Lymphomas (Oncology) - Drugs in Development, 2021 SUMMARY Natural Killer Cell Lymphomas (Oncology) - Drugs in Development, 2021 provides an overview of the Natural Killer Cell Lymp...

April 2021 100 pages

Nausea (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Nausea (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Nausea (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Nausea pipeline landscape. The report provides compreh...

April 2021 40 pages

Necrotizing Enterocolitis (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Necrotizing Enterocolitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Necrotizing Enterocolitis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Necrotizing Ente...

April 2021 40 pages

Neisseria Gonorrhoeae Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Neisseria Gonorrhoeae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Neisseria Gonorrhoeae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of th...

April 2021 35 pages

Neonatal Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Neonatal Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021 SUMMARY Neonatal Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021 provides an overview of the...

April 2021 35 pages

Nerve Injury (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Nerve Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Nerve Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Nerve Injury pipeline landscap...

April 2021 30 pages

Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) (Genetic Disorders) - Dru...

April 2021 40 pages

Neuroendocrine Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Neuroendocrine Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Neuroendocrine Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Neuroendocrine Cancer pipeline landscape...

April 2021 45 pages

Neuroendocrine Carcinoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Neuroendocrine Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Neuroendocrine Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Neuroendocrine Carcinoma pipeline...

April 2021 40 pages

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) (Oncology) - Drugs in Development, 2021 SUMMARY Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) (Oncology) - Drugs in Development, 2021 pr...

April 2021 55 pages

Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) - Drugs in Development, 2021

US$ 3,000.00

Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) - Drugs in Development, 2021 SUMMARY Neurogenic Locus Notch Homolog Protein 1 (Translocation Associate...

April 2021 35 pages

Neuroinflammation (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Neuroinflammation (Central Nervous System) - Drugs in Development, 2021 SUMMARY Neuroinflammation (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Neuroinflammation pi...

April 2021 90 pages

Neuromedin K Receptor (NK3 Receptor or Neurokinin B Receptor or Tachykinin Receptor 3 or NK3R or TACR3) - Drugs in Development, 2021

US$ 3,000.00

Neuromedin K Receptor (NK3 Receptor or Neurokinin B Receptor or Tachykinin Receptor 3 or NK3R or TACR3) - Drugs in Development, 2021 SUMMARY Neuromedin K Receptor (NK3 Receptor or Neurokinin B Recepto...

April 2021 30 pages

Neuromuscular Disorders (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Neuromuscular Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Neuromuscular Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Neuromus...

April 2021 55 pages

Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) - Drugs in Development, 2021

US$ 3,000.00

Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) - Drugs in Development, 2021 SUMMARY Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) - Drugs in Development, 2021 provides in depth an...

April 2021 30 pages

Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) - Drugs in Development, 2021

US$ 3,000.00

Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) - Drugs in Development, 2021 SUMMARY Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) - Drugs in Development, 2021 provides in depth anal...

April 2021 30 pages

Neuropathic Pain (Neuralgia) (Central Nervous System) - Drugs in Development, 2021

US$ 2,500.00

Neuropathic Pain (Neuralgia) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Neuropathic Pain (Neuralgia) (Central Nervous System) - Drugs in Development, 2021 provides an overview of th...

April 2021 325 pages

Neuropathy (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Neuropathy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Neuropathy (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Neuropathy pipeline landscape. The...

April 2021 35 pages

Neuropilin 1 (Vascular Endothelial Cell Growth Factor 165 Receptor or CD304 or NRP1) - Drugs in Development, 2021

US$ 3,000.00

Neuropilin 1 (Vascular Endothelial Cell Growth Factor 165 Receptor or CD304 or NRP1) - Drugs in Development, 2021 SUMMARY Neuropilin 1 (Vascular Endothelial Cell Growth Factor 165 Receptor or CD304 or...

April 2021 30 pages

Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) - Drugs in Development, 2021

US$ 3,000.00

Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) - Drugs in Development, 2021 SUMMARY Neurotensin Receptor Type 1 (NTR1 or High Affin...

April 2021 30 pages

Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) - Drugs in Development, 2021

US$ 3,000.00

Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) - Drugs in Development, 2021 SUMMARY Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) - Drugs in Development, 2021 provides in depth analysis...

April 2021 35 pages

Nicotine Addiction (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Nicotine Addiction (Central Nervous System) - Drugs in Development, 2021 SUMMARY Nicotine Addiction (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Nicotine Addiction...

April 2021 65 pages

Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021

US$ 3,000.00

Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 SUMMARY Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 provides in depth analysis on Niemann Pick C1 Like Pro...

April 2021 35 pages

Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021

US$ 3,000.00

Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021 SUMMARY Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021 provides in depth analysis on Niemann Pick C1 Protein (NPC1) targeted pi...

April 2021 30 pages

Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) - Drugs in Development, 2021

US$ 3,000.00

Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) - Drugs in Development, 2021 SUMMARY Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) - Drugs in Development, 2021 provides in de...

April 2021 35 pages

Nodal Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Nodal Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Nodal Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Nodal Margin...

April 2021 50 pages

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021 SUMMARY Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncolog...

April 2021 115 pages

Non-Proliferative Diabetic Retinopathy (NPDR) (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Non-Proliferative Diabetic Retinopathy (NPDR) (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Non-Proliferative Diabetic Retinopathy (NPDR) (Metabolic Disorders) - Drugs in Development, 202...

April 2021 35 pages

Non-Small Cell Lung Carcinoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Non-Small Cell Lung Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Non-Small Cell Lung Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Non-Small Cell Lung Carc...

April 2021 110 pages

Nonerosive Reflux Disease (NERD) (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Nonerosive Reflux Disease (NERD) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Nonerosive Reflux Disease (NERD) (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the No...

April 2021 30 pages

Nongerminomatous (Nonseminomatous) Germ Cell Tumors (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Nongerminomatous (Nonseminomatous) Germ Cell Tumors (Oncology) - Drugs in Development, 2021 SUMMARY Nongerminomatous (Nonseminomatous) Germ Cell Tumors (Oncology) - Drugs in Development, 2021 provides...

April 2021 30 pages

Nonmelanomatous Skin Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Nonmelanomatous Skin Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Nonmelanomatous Skin Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Nonmelanomatous Skin Cancer...

April 2021 35 pages

Nonstructural Protein 1 (NS1) - Drugs in Development, 2021

US$ 3,000.00

Nonstructural Protein 1 (NS1) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 1 (NS1) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 1 (NS1) targeted pipel...

April 2021 35 pages

Nonstructural Protein 3 (NS3) - Drugs in Development, 2021

US$ 3,000.00

Nonstructural Protein 3 (NS3) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 3 (NS3) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 3 (NS3) targeted pipel...

April 2021 30 pages

Nonstructural Protein 4B (NS4B) - Drugs in Development, 2021

US$ 3,000.00

Nonstructural Protein 4B (NS4B) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 4B (NS4B) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 4B (NS4B) targeted...

April 2021 30 pages

Nonstructural Protein 5A (NS5A) - Drugs in Development, 2021

US$ 3,000.00

Nonstructural Protein 5A (NS5A) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 5A (NS5A) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 5A (NS5A) targeted...

April 2021 60 pages

Norovirus Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Norovirus Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Norovirus Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Norovirus Infections p...

April 2021 50 pages

NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) - Drugs in Development, 2021

US$ 3,000.00

NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) - Drugs in Development, 2021 SUMMARY NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) - Drugs in Development, 2021 provides in depth...

April 2021 55 pages

Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6) - Drugs in Development, 2021

US$ 3,000.00

Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6) - Drugs in Development, 2021 SUMMARY Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6)...

April 2021 35 pages

Filters

Clear all